The funds will be used to increase the development of GAIA-based Alzheimer's Disease drugs and widen the pipeline of blockbuster drug candidates.

The company will use the funds to move into the female health space and increase screening and preventive care.

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

NEW YORK - At HIMSS AI Forum on Friday, during the talk, "The future of people centered care: earning (or losing) trust by leveraging AI and synthetic research," Dr. Adrienne Boissy, chief medical ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

A new AI algorithm developed by researchers from the University of Western Australia has been found to better predict the ...

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...

The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more ...

The organizations will co-develop AI playbooks, tools, a new certification program and best practices for health AI.

Flinders University has developed an online program that seeks to improve the way people with inflammatory bowel disease (IBD ...

Editor's note: This story has been updated with additional information on Pear's financial state. The assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold ...